Skip to content

Dr. rer. nat. Barbara Jentges

Barbara Jentges is Managing Director of Phact GmbH.

Phact Management Director Dr. Barbara Jentges

Barbara is a Senior Drug Regulatory Affairs Expert with more than 24 years of experience in the area of Drug Regulatory Affairs, in particular in the field of small molecule and biotech pharmaceutical products. She teaches at ETH (Swiss Federal Institute of Technology), Department of Chemistry and Applied Biosciences in Zurich, Switzerland, in the Master´s curriculum Medicinal and Industrial Pharmaceutical Sciences (MSc MIPS) and at the FHNW (University of Applied Sciences and Arts North-western Switzerland), School of Life Sciences, Muttenz/Basel, Switzerland. She worked for a long time as an assessor of the Federal Institute for Drugs and Medical Devices (BfArM: Bundesinstitut für Arzneimittel und Medizinprodukte) in Germany.

Within the Parenteral Drug Association (PDA) Barbara was a member of PDAs Regulatory Affairs and Quality Advisory Board and served as the European co-chair of PDAs Regulatory Affairs Interest Group.

As an editor and co-author she recently published the second edition of a book titled regarding Pharmaceutical Legislation of the European Union, Japan and the United States of America – An Overview (Second Edition 2016) issued by the Parenteral Drug Association, Inc., Bethesda, MD 20815, US.

Barbara studied pharmacy at the University of Frankfurt/M.,Germany, and obtained a doctorate in pharmaceutical chemistry from the University of Tübingen/Germany in 1990.

Managing Director of Phact GmbH (since 2006).
___
Assessor at the Federal Institute for Drugs and Medical Devices (BfArM), Germany,
according to §25.5 and §105 of the German drug law (AMG).
___
Project manager (drug regulatory affairs, GMP) with Concept Heidelberg, Germany.
___
Owner of a public pharmacy with a manufacturing license according to the German Drug Law (AMG); certified as ‘Qualified Person’ according to § 15 of German drug law (AMG).
___

Lecturer at the Swiss Federal Institute of Technology (ETH) in Zurich / Switzerland in the Master´s programme “MSc Pharmaceutical Sciences”.
___
Lecturer at the University of Applied Sciences and Arts Northwestern (FHNW), School of Life Sciences, Institute of Pharmaceutical Technology, Muttenz /Switzerland.
___
Member of the Curriculum Committee and lecturer of the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel AG), Bern/Switzerland.
___
Lecturer at the Bern University of Applied Sciences, Bern / Switzerland.
___

Barbara Jentges (ed.), Denyse Baker, Takayoshi Matsumura, Joanne S. Hawana.
Pharmaceutical Legislation of the European Union, Japan and the United States of America – An Overview.
Updated and Expanded 2nd. Edition.
Parenteral Drug Association, Inc., 2013, 2016.
__________
Brigitte Friese, Barbara Jentges, Usfeya A. Muazzam.
Guide to Drug Regulatory Affairs.
Editio Cantor Verlag Aulendorf (Germany). 2009.
__________

Former European Co-Chair of PDAs Interest Group ‘Regulatory Affairs’.
___
Former member of PDAs ‘Regulatory and Quality Advisory Board’ (RAQAB).
___